Cresco Labs (CRLBF) Equity Income (2020 - 2025)
Cresco Labs (CRLBF) reported Equity Income of -$152000.0 for Q3 2025, up 0.65% quarter-over-quarter from -$153000.0 in Q2 2025.
Cresco Labs (CRLBF) Equity Income (2020 - 2025) Analysis & Trends
Cresco Labs has reported Equity Income for 2 years, with the latest figure at -$152000.0 in Q3 2025.
- For the quarter ending Q3 2025, Equity Income changed N/A year-over-year to -$152000.0; the trailing twelve-month figure through Sep 2025 stood at -$89000.0 (changed N/A YoY), and the FY2021 full-year result was -$1.2 million, down 1.27% from the prior year.
- Equity Income for Q3 2025 stood at -$152000.0, up from -$153000.0 in the prior quarter.
- The five-year high for Equity Income was $216000.0 in Q1 2025, with the low at -$153000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.68 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.91 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -152,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2020 | -927,000.00 |
| Sep 30, 2020 | -134,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Mar 31, 2020 | -144,000.00 |